Provided herein are pyrimidinyl and 1,3,5-triazinyl benzimidazoles of Formula (I), (1A), (1B) and their pharmaceutical compositions, preparation, and use as agents or drugs for cancer therapy, either alone or in combination with radiation and/or other anticancer drugs.